Life Sciences Corporate Venture Investing: Where’s The Heartbeat And How’s The Patient?

Posted 11/02/05 at 1:55 pm

A panel discussion led by Bruce W. Jenett of Heller Ehrman LLP on November 2, 2005 at Heller Ehrman premises starting at 6:15 PM. Panelists include:

  • Dr. Brad Vale, Johnson & Johnson Development Corporation
  • Eran Raber, Investment Manager, Agilent Capital
  • Richard Fuentes, Corporate Venture Capital, Dow Chemical Company
  • Jim Adair, Vice President, Business development, Genentech.

View the invitation for this Event (.doc)